Initial Management of Cardiogenic Shock Due to Myocarditis in Pediatrics
Initial Assessment and Stabilization
- The American Heart Association recommends immediate evaluation with ECG and echocardiography for diagnosis and to guide management in all pediatric patients with suspected cardiogenic shock due to myocarditis 1
- Continuous monitoring of ECG, arterial pressure, and tissue perfusion markers should be established in pediatric patients with cardiogenic shock due to myocarditis 1
- Invasive arterial line placement is recommended for continuous blood pressure monitoring and frequent blood sampling in pediatric patients with cardiogenic shock due to myocarditis 1
Pharmacological Management
- The American College of Cardiology recommends individualized titration of inotropic support with epinephrine, levosimendan, dopamine, or dobutamine in pediatric patients with cardiogenic shock due to myocarditis 2, 3
- Dopamine should be used with caution at doses >7 mcg/kg/min as it may increase pulmonary vascular resistance in pediatric patients with cardiogenic shock due to myocarditis 4, 5
- Levosimendan has shown improved ejection fraction and reduced duration of catecholamine infusions in small studies of pediatric patients with cardiogenic shock due to myocarditis 4, 5
- Norepinephrine may be considered for maintaining mean arterial pressure >65 mmHg in pediatric patients with cardiogenic shock due to myocarditis, although data are limited 6
Ventilation Strategy
- There is insufficient evidence to support or refute early intubation before the onset of respiratory failure in pediatric shock, according to the American Heart Association 7, 8
- Mechanical ventilation should be considered when there are signs of respiratory distress or failure in pediatric patients with myocarditis, with careful attention to hemodynamics during the procedure 9
Mechanical Circulatory Support
- Early consideration of extracorporeal membrane oxygenation (ECMO) is warranted in pediatric myocarditis with cardiogenic shock that is refractory to pharmacological therapy, according to the American Heart Association 9
- Very low-quality evidence suggests that pre-cardiac arrest use of ECMO may be beneficial in children with acute fulminant myocarditis 9
Monitoring and Ongoing Assessment
- Serial echocardiography should be performed to assess ventricular function and response to therapy in pediatric patients with cardiogenic shock due to myocarditis 1
- Regular assessment of end-organ perfusion through clinical examination, urine output, and laboratory parameters should be performed in pediatric patients with cardiogenic shock due to myocarditis 1
Common Pitfalls to Avoid
- Delaying echocardiographic evaluation is a common pitfall to avoid in the management of pediatric patients with cardiogenic shock due to myocarditis 1
- Relying solely on blood pressure for assessment without evaluating tissue perfusion markers is a common pitfall to avoid in the management of pediatric patients with cardiogenic shock due to myocarditis 1
Management of Cardiogenic Shock Due to Myocarditis in Pediatrics
Pharmacological Management
- The American Heart Association recommends considering pulmonary artery catheter monitoring for management of refractory shock, as suggested in guidelines published in Circulation 10
- Dobutamine may be used at doses of 2-20 mcg/kg/min for myocardial dysfunction with adequate blood pressure, according to research published in Circulation 10
Mechanical Circulatory Support
- The American College of Cardiology recommends considering ECMO when cardiac index <2.2 L/min/m², cardiac power output <0.6 W, and elevated lactate despite initial therapy, as outlined in JACC: Heart Failure 11